Table 2.
Prioritized list of coding sequence variants between the Py17X and Py17XNL genomes
| Py17X gene ID | Py17XNL gene ID | Gene name | Chromosome position | Py17X DNA | Py17XNL DNA | Mutation type | AA change | Protein alignment |
|---|---|---|---|---|---|---|---|---|
| PY17X_0811400 | Py17XNL_0801678 | Proteasome subunit alpha type-3.1 | 529296 | G | A | Missense variant | Val24Ile | Py17X MAGLSAGYDLSVSTFSPDGRLYQVEYIYKAINNNNTSISLECKDGVISCSINTSLEKNKMIKKNSYNRIYYV |
| 17XNL MAGLSAGYDLSVSTFSPDGRLYQIEYIYKAINNNNTSISLECKDGVISCSINTSLEKNKMIKKNSYNRIYYV | ||||||||
| Cons ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗:∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ | ||||||||
| PY17X_0316900 | Py17XNL_0303734 | Plasmodium exported protein | 625346 | G | A | Missense variant | Gly1324Ser | Py17X PEQKENGDIGEASNNAAELKENMNDLLKDTIEISKESIKEHDAQSIMFTRKFIKHVSGYDIQKAKDHPTDED |
| 17XNL PEQKENGDIGEASNNAAELKENMNDLLKDTIEISKESIKEHDAQSIMFTRKFIKHVSSYDIQKAKDHPTDED | ||||||||
| Cons ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗.∗∗∗∗∗∗∗∗∗∗∗∗∗∗ | ||||||||
| PY17X_1022000 | Py17XNL_1002268 | PP7 | 964836 | C | A | Missense variant | Leu342Phe | Py17X FAFKLSNYDSVIINRGNHECSYMNEVYGFHNEVLSKYDESVFDIFQEIFELLSLSVNIQNQIFVVHGGLSRY |
| 17XNL FAFKLSNYDSVIINRGNHECSYMNEVYGFHNEVLSKYDESVFDIFQEIFELLSFSVNIQNQIFVVHGGLSRY | ||||||||
| Cons ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗:∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ | ||||||||
| PY17X_1419800 | Py17XNL_1401046 | ACDC domain-containing protein | 839701 | G | T | Missense variant | Arg1562Ile | Py17X VNENFTAELNGVQMYNGNEKKKKKKNYSLSINKNNGNIKDNENTNEILLRYENEVYAPNNDVEKNLIEDNNI |
| 17XNL VNENFTAELNGVQMYNGNEKKKKKKNYSLSINKNNGNIKDNENTNEILLIYENEVYAPNNDVEKNLIEDNNI | ||||||||
| Cons ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗:∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ | ||||||||
| PY17X_0106400 | Py17XNL_0104725 | RNA-binding protein | 339741 | AGATAGG | A | Disruptive in-frame deletion | Asp578_Arg579del | Py17X RDRDRDRDRDRDRDRDRDRDRDRR |
| 17XNL RDRDR--DRDRDRDRDRDRDRDRR | ||||||||
| Cons ∗∗∗∗∗ ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ | ||||||||
| PY17X_1206500 | Py17XNL_1204935 | UTP25 | 344114 | GGAAAATGGGAAT | G | Disruptive in-frame deletion | Gly163_Asn166del | Py17X ENGNENGNENGNENGNENGNENDKNGNDKNGNDKNGNDKNEASSFQSKDEIYMNILINNIKSQNEDFLNVKE |
| 17XNL ENGNENGNENGNENGNEN----DKNGNDKNGNDKNGNDKNEASSFQSKDEIYMNILINNIKSQNEDFLNVKE | ||||||||
| Cons ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ | ||||||||
| PY17X_1110800 | Py17XNL_1105517 | KH domain-containing protein | 539935 | G | GTTA | Disruptive in-frame insertion | Asn1809dup | Py17X NNNVGRDNIIRKENKGIMMHDDKDKFSKGGNNRYFGDKTNNFNNKN-NNNNNNNNNNNNNNNNNNAKNNYLSKDSMI |
| 17XNL NNNVGRDNIIRKENKGIMMHDDKDKFSKGGNNRYFGDKTNNFNNKNNNNNNNNNNNNNNNNNNNNAKNNYLSKDSMI | ||||||||
| Cons ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ | ||||||||
| PY17X_1334500 | Py17XNL_1303202 | AP2-SP | 1594433 | AAC, T, AC | GCT, C, TA | Synonymous and missense variant | Val133Tyr, Val136Ser | Py17X QINYNISNDIMNTVPSTNCDVTHDSVSSVPNNAFENVENVKNVENVENVKNVENVENVENVENVENVENYEN |
| 17XNL QINYNISNDIMNTVPSTNCDVTHDSVSSVPNNAFENVENVKNVENVENVKNVENVENVENYENSENVENYEN | ||||||||
| Cons ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ ∗∗ ∗∗∗∗∗∗∗∗ | ||||||||
| PY17X_1128400 | Py17XNL_1105678 | PK4 | 1187719 | T | TGAA | Conservative in-frame insertion | Glu266dup | Py17X FYNSYNYCNNNNSKRDEKIEKNIVEKNIENKYNIKEYDKTNKSILFPIE-EFKKIIQIENNIERNYIVPKES |
| 17XNL FYNSYNYCNNNNSKRDEKIEKNIVEKNIENKYNIKEYDKTNKSILFPIEEEFKKIIQIENNIERNYIVPKES | ||||||||
| Cons ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ | ||||||||
| PY17X_1451200 | Py17XNL_1401341 | BDP5 | 2018932 | A | AAATATAAAC | Disruptive in-frame insertion | Asn320_Asn321insAsnIleAsn | Py17X NKIRSKNEINNSPNTDKVEKNIN---NINNINNINNNTNNNNVHEYVPNNLNDEFIEEKKLDKNKFNEYKNN |
| 17XNL NKIRSKNEINNSPNTDKVEKNINNINNINNINNINNNTNNNNVHEYVPNNLNDEFIEEKKLDKNKFNEYKNN | ||||||||
| Cons ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ | ||||||||
| PY17X_0942100 | Py17XNL_0900429 | PAIP1 | 1662686 | A | AAAT | Disruptive in-frame insertion | Asn1941dup | Py17X NVNKNKEIGKDEIQINSQINNLDDNAKGKKSNIFNQAKSSYKYPAEEGENNSNTNTSTEN-NNNNNNNNNNKT |
| 17XNL NVNKNKEIGKDEIQINSQINNLDDNAKGKKSNIFNQAKSSYKYPAEEGENNSNTNTSTENNNNNNNNNNNNKT | ||||||||
| Cons ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ ∗∗∗∗∗∗∗∗∗∗∗∗ | ||||||||
| PY17X_0106100 | Py17XNL_0104722 | RAD50 | 324089 | CGTT | C | Disruptive in-frame deletion | Gln834del | Py17X ENITNCVNKNEDILSDNLIKLESKKRVTAHFEELENGMKKKQRQEQDKFETVQKMKIEKIEKISKIEKINKI |
| 17XNL ENITNCVNKNEDILSDNLIKLESKKRVTAHFEELENGMKKK-RQEQDKFETVQKMKIEKIEKISKIEKINKI | ||||||||
| Cons ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ | ||||||||
| PY17X_1001900 | Py17XNL_1204888 | Erythrocyte membrane antigen 1 | 174565 | TAAATGA | T | Conservative in-frame deletion | Asn287_Glu288del | Py17X SYLNNGENAEDQELDDEVASCFADGENVNDKELDEVISYLANGENVNVNVNENVNENVNENVNENENENENE |
| 17XNL SYLNNGENAEDQELDDEVASCFADGENVNDKELDEVISYLANGENVNVNVNENVNENVNENVNE--NENENE | ||||||||
| Cons ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ ∗∗∗∗∗∗ |
AA, amino acid.